| 1 |
35265066 | T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages. | 2022 |
1 |
| 2 |
34573098 | The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy. | 2021 Sep 15 |
1 |
| 3 |
29953997 | Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling. | 2018 |
1 |
| 4 |
26918785 | CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages. | 2016 |
1 |
| 5 |
25105464 | The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock. | 2014 Nov |
1 |
| 6 |
23741300 | The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis. | 2013 |
1 |
| 7 |
18587580 | CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. | 2009 Mar |
5 |
| 8 |
18413761 | Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3. | 2008 Apr 15 |
3 |